Study of clinical course of organ dysfunction in intensive care

被引:32
作者
Doig, CJ [1 ]
Zygun, DA
Fick, GH
Laupland, KB
Boiteau, PJE
Shahpori, R
Rosenal, T
Sandham, JD
机构
[1] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
关键词
multiple organ failure; critical care; cohort studies; natural history;
D O I
10.1097/01.CCM.0000108881.14082.10
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Multiple organ dysfunction is a common cause of death in intensive care units. We describe the daily course of multiple organ dysfunction measured by the Sequential Organ Failure Assessment score in a population-based cohort of critically ill patients. Design: Prospective cohort study. Setting: Adult multisystem intensive care units in the Calgary Health Region. Patients: A total of 1,436 patients admitted from May 1, 2000 to April 30, 2001. Measurements: Temporal change in Sequential Organ Failure Assessment score. Interventions: None; observational study. Main Results: The mean age was 58 yrs (range, 14-100). The mean +/- SD intensive care unit admission Acute Physiology and Chronic Health Evaluation II score was 25 +/- 9. The median intensive care unit length of stay was 4 days (interquartile range, 2-8), and the median hospital length of stay was 15 days (interquartile range, 7-32). A total of 20.5% of patients were infected at admission, and 26.0% were immediately postoperative. Intensive care unit mortality was 27.0%, and hospital mortality was 35.1%. The daily Sequential Organ Failure Assessment score was significantly higher in nonsurvivors than survivors. A population-averaged model determined a mean rate of change of Sequential Organ Failure Assessment score to be -0.29 per day (95% confidence interval, -0.32 to -0.25) for survivors and -0.03 per day (95% confidence interval, -0.08 to 0.03) for nonsurvivors (overall regression, p < .0001). Patients with infection had higher admission Sequential Organ Failure Assessment scores compared with patients without infection (difference, 1.8; p < .001), but a similar rate of daily change. Conclusions: Multiple organ dysfunction, does not follow a course of progressive and sequential failure. Evidence of differential daily change should further inform the use of organ failure scores as surrogate outcomes in clinical trials.
引用
收藏
页码:384 / 390
页数:7
相关论文
共 35 条
[1]  
BAUE AE, 1975, ARCH SURG-CHICAGO, V110, P779
[2]  
Baue AE, 1997, ARCH SURG-CHICAGO, V132, P703
[3]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[4]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]   The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction [J].
Bota, DP ;
Melot, C ;
Ferreira, FL ;
Ba, VN ;
Vincent, JL .
INTENSIVE CARE MEDICINE, 2002, 28 (11) :1619-1624
[6]   Users' guides to the medical literature XIX. Applying clinical trial results A. How to use an article measuring the effect of an intervention on surrogate end points [J].
Bucher, HC ;
Guyatt, GH ;
Cook, DJ ;
Holbrook, A ;
McAlister, FA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :771-778
[7]   New strategies for clinical trials in patients with sepsis and septic shock [J].
Cohen, J ;
Guyatt, G ;
Bernard, GR ;
Calandra, T ;
Cook, D ;
Elbourne, D ;
Marshall, J ;
Nunn, A ;
Opal, S .
CRITICAL CARE MEDICINE, 2001, 29 (04) :880-886
[8]   A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation [J].
Cook, D ;
Guyatt, G ;
Marshall, J ;
Leasa, D ;
Fuller, H ;
Hall, R ;
Peters, S ;
Rutledge, F ;
Griffith, L ;
McLellan, A ;
Wood, G ;
Kirby, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12) :791-797
[9]   Multiple organ dysfunction: Baseline and serial component scores [J].
Cook, R ;
Cook, D ;
Tilley, J ;
Lee, KA ;
Marshall, J .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2046-2050
[10]   MULTIPLE ORGAN FAILURE - PATHOPHYSIOLOGY AND POTENTIAL FUTURE THERAPY [J].
DEITCH, EA .
ANNALS OF SURGERY, 1992, 216 (02) :117-134